These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 17085341

  • 21. Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA.
    Li L, Xu J, Min T, Huang W.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):93-7. PubMed ID: 16564522
    [Abstract] [Full Text] [Related]

  • 22. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
    Tsang WP, Kwok TT.
    Oncogene; 2007 Jul 19; 26(33):4877-81. PubMed ID: 17297456
    [Abstract] [Full Text] [Related]

  • 23. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A, Holm PS, Lage H.
    Int J Oncol; 2007 Aug 19; 31(2):419-30. PubMed ID: 17611700
    [Abstract] [Full Text] [Related]

  • 24. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C, Calabretta B.
    Cancer Res; 1996 Oct 01; 56(19):4332-7. PubMed ID: 8813118
    [Abstract] [Full Text] [Related]

  • 25. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
    Zheng LH, Bao YL, Wu Y, Yu CL, Meng X, Li YX.
    Cancer Lett; 2008 Dec 08; 272(1):102-9. PubMed ID: 18703276
    [Abstract] [Full Text] [Related]

  • 26. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004 Dec 08; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 27. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
    Campling BG, Young LC, Baer KA, Lam YM, Deeley RG, Cole SP, Gerlach JH.
    Clin Cancer Res; 1997 Jan 08; 3(1):115-22. PubMed ID: 9815546
    [Abstract] [Full Text] [Related]

  • 28. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
    Stege A, Priebsch A, Nieth C, Lage H.
    Cancer Gene Ther; 2004 Nov 08; 11(11):699-706. PubMed ID: 15375376
    [Abstract] [Full Text] [Related]

  • 29. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 08; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 30. Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma.
    Song X, Wang JB, Yin DL, Yang HY, Liu LX, Jiang HC.
    Chin Med J (Engl); 2009 Nov 05; 122(21):2636-42. PubMed ID: 19951584
    [Abstract] [Full Text] [Related]

  • 31. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L, Chen XP, Zhang ZW, Wang H, Cao B, Wang ZH, Li CL.
    Zhonghua Wai Ke Za Zhi; 2005 Oct 01; 43(19):1248-53. PubMed ID: 16271222
    [Abstract] [Full Text] [Related]

  • 32. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
    Fairchild CR, Moscow JA, O'Brien EE, Cowan KH.
    Mol Pharmacol; 1990 Jun 01; 37(6):801-9. PubMed ID: 1972772
    [Abstract] [Full Text] [Related]

  • 33. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X, Liu T, Gong Y, Zheng B, Meng W, Leng Y.
    Leuk Res; 2009 Aug 01; 33(8):1114-9. PubMed ID: 19036441
    [Abstract] [Full Text] [Related]

  • 34. [Study of mdr1 antisense oligodeoxynucleotides on reversal of multidrug resistance in ovarian carcinoma cell line SKOV3].
    Tong Y, Pan L, Zhou S.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov 01; 35(11):677-9. PubMed ID: 11218898
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
    He Y, Zhang J, Zhang J, Yuan Y.
    Chin Med J (Engl); 2000 Sep 01; 113(9):848-51. PubMed ID: 11776085
    [Abstract] [Full Text] [Related]

  • 37. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
    Ding L, Chen XP, Zhang ZW, Jing K, Zhang WG.
    Hepatobiliary Pancreat Dis Int; 2007 Aug 01; 6(4):393-8. PubMed ID: 17690036
    [Abstract] [Full Text] [Related]

  • 38. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL, Zhai HY, Chen BY, Zhai SP, Yang HY, Chen XP, Zhao WT, Meng L.
    Hepatobiliary Pancreat Dis Int; 2004 May 01; 3(2):296-9. PubMed ID: 15138130
    [Abstract] [Full Text] [Related]

  • 39. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y, Qian F, Wei D, Liu J.
    J Pharm Pharmacol; 2004 Oct 01; 56(10):1307-14. PubMed ID: 15482646
    [Abstract] [Full Text] [Related]

  • 40. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.
    Yagüe E, Higgins CF, Raguz S.
    Gene Ther; 2004 Jul 01; 11(14):1170-4. PubMed ID: 15164094
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.